The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study-Reference-Cited by-同舟云学术

The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study

Published:2022-10-15 Issue:11 Volume:36 Page:1207-1216
ISSN:1172-7047
Container-title:CNS Drugs
language:en
Short-container-title:CNS Drugs

Author:

Frank Samuel^ORCID,Testa Claudia,Edmondson Mary C.,Goldstein Jody,Kayson Elise,Leavitt Blair R.,Oakes David,O’Neill Christine,Vaughan Christina,Whaley Jacquelyn,Gross Nicholas,Gordon Mark Forrest^ORCID,Savola Juha-Matti^ORCID,Frank Samuel^ORCID,Testa Claudia,Stamler David,Kayson Elise,Edmondson Mary C.,Leavitt Blair R.,Oakes David,O’Neill Christine,Vaughan Christina,Goldstein Jody,Bockus Margaret,Leyva Stephanie,Snively Victoria,Whaley Jacquelyn,Wong Cynthia,Mallonee William M.,Suter Gregory,Jankovic Joseph,Jimenez-Shahed Joohi,Hunter Christine,Claassen Daniel O.,West Lauren,Roman Olivia,Sung Victor,Smith Jenna,Clouse Ronda,Saint-Hilaire Marie,Turpin Denyse,James Raymond,Rodriguez Ramon,Rizer Kyle,Anderson Karen,Heller Hope,Ahmad Alexis,Criswell Susan,Racette Brad A.,Nucifora Jr Frederick C.,Churchill Gregory,Ong MaryJane,Mendis Tilak,Mendis Neila,Singer Carlos,Paulsen Jane S.,Kerr Jane,Dubinsky Richard,Gray Carolyn,Factor Stewart A.,Sperin Elaine,Molho Eric,Evans Sharon,Nickels Breanna,Bergen Courtney,Jaynes Jessica,Reeves Christina,Segro Vicki,Samii Ali,Christopher Emily,Del Castillo Debra,Chouinard Sylvain,Perry-Trice Peggy,Esmail Sherali,Fung Wai Lun Alan,Gibbons Clare,Colcher Amy,Hackmyer Cory,McGarry Andrew,Klos Kevin,Gudesblatt Mark,Schneider Daniel,Dhall Rohit,Simpson Edith,Wojcieszek Joanne,Hurt Andrea,LaFaver Kathrin,Robinson Annette,Revilla Fredy J.,Duker Andrew P.,Neefus Erin,Wilson-Perez Hilary,Shprecher David,Hohnholt Tyler,Wall Paola,Boyd James,Houston Emily,Farbman Eric S.,Poynor Shamine,Agarwal Pinky,Leon Julissa,Eberly Shirley,Watts Arthur,Tariot Pierre,Feigin Andrew,Evans Scott R.,Beck Christopher A.,

Funder

Teva Pharmaceutical Industries, Tel Aviv, Israel

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Psychiatry and Mental health,Neurology (clinical)

Link

https://link.springer.com/content/pdf/10.1007/s40263-022-00956-8.pdf

Reference21 articles.

1. Foroud T, Gray J, Ivashina J, Conneally PM. Differences in duration of Huntington’s disease based on age at onset. J Neurol Neurosurg Psychiatry. 1999;66(1):52–6. https://doi.org/10.1136/jnnp.66.1.52.

2. Jankovic J. Treatment of hyperkinetic movement disorders. Lancet Neurol. 2009;8(9):844–56. https://doi.org/10.1016/S1474-4422(09)70183-8.

3. Testa CM, Jankovic J. Huntington disease: a quarter century of progress since the gene discovery. J Neurol Sci. 2019;396:52–68. https://doi.org/10.1016/j.jns.2018.09.022.